Financial Instruments (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Product Information [Line Items]
Fair Value, Concentration of Risk, Accounts Receivable	$ 62,329	$ 0
Concentration of revenues	$ 303,750	$ 346,144
Customer Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member] | Customer A [Member]
Product Information [Line Items]
Concentration risk, percentage	33.40%	26.10%
Concentration of revenues	$ 106,988	$ 190,313
Customer Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member] | Customer B [Member]
Product Information [Line Items]
Concentration risk, percentage	29.30%	51.00%
Concentration of revenues	$ 93,622	$ 190,313
Customer Concentration Risk [Member] | Revenue from Contract with Customer Benchmark [Member] | Customer C [Member]
Product Information [Line Items]
Concentration risk, percentage	14.90%	0.00%
Concentration of revenues	$ 47,604	$ 0